Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 10 studies | 25% ± 10% | |
retinal rod cell | 4 studies | 23% ± 4% | |
retinal cone cell | 3 studies | 26% ± 7% |
Insufficient scRNA-seq data for expression of CERKL at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 576.60 | 89 / 89 | 43% | 1.30 | 383 / 901 |
lung | 100% | 834.38 | 576 / 578 | 28% | 0.89 | 327 / 1155 |
intestine | 95% | 466.76 | 922 / 966 | 13% | 0.28 | 67 / 527 |
spleen | 100% | 2750.84 | 241 / 241 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 1280.57 | 912 / 929 | 0% | 0 | 0 / 0 |
breast | 81% | 167.47 | 370 / 459 | 16% | 0.45 | 184 / 1118 |
stomach | 79% | 139.41 | 283 / 359 | 13% | 0.26 | 36 / 286 |
adipose | 87% | 191.07 | 1043 / 1204 | 0% | 0 | 0 / 0 |
prostate | 80% | 166.32 | 197 / 245 | 2% | 0.02 | 8 / 502 |
brain | 51% | 276.01 | 1340 / 2642 | 30% | 0.88 | 214 / 705 |
bladder | 71% | 204.43 | 15 / 21 | 6% | 0.15 | 29 / 504 |
thymus | 65% | 149.94 | 424 / 653 | 4% | 0.06 | 25 / 605 |
uterus | 61% | 145.95 | 103 / 170 | 6% | 0.19 | 29 / 459 |
liver | 62% | 91.42 | 141 / 226 | 4% | 0.09 | 18 / 406 |
esophagus | 55% | 83.73 | 795 / 1445 | 10% | 0.19 | 18 / 183 |
blood vessel | 57% | 126.66 | 757 / 1335 | 0% | 0 | 0 / 0 |
pancreas | 28% | 40.15 | 93 / 328 | 19% | 0.56 | 33 / 178 |
skin | 45% | 296.29 | 814 / 1809 | 1% | 0.02 | 6 / 472 |
adrenal gland | 38% | 48.97 | 99 / 258 | 5% | 0.10 | 11 / 230 |
ovary | 21% | 27.16 | 37 / 180 | 5% | 0.12 | 23 / 430 |
lymph node | 0% | 0 | 0 / 0 | 14% | 0.20 | 4 / 29 |
heart | 13% | 17.54 | 114 / 861 | 0% | 0 | 0 / 0 |
muscle | 9% | 23.17 | 71 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 1% | 0.03 | 1 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0030148 | Biological process | sphingolipid biosynthetic process |
GO_0016310 | Biological process | phosphorylation |
GO_0006665 | Biological process | sphingolipid metabolic process |
GO_0005730 | Cellular component | nucleolus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0001917 | Cellular component | photoreceptor inner segment |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0001750 | Cellular component | photoreceptor outer segment |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0001727 | Molecular function | lipid kinase activity |
GO_0046625 | Molecular function | sphingolipid binding |
Gene name | CERKL |
Protein name | Ceramide kinase-like Ceramide kinase like Ceramide kinase-like protein Ceramide kinase like (Ceramide kinase-like isoform 8) (Ceramide kinase-like protein isoform 8) |
Synonyms | hCG_1776884 |
Description | FUNCTION: Has no detectable ceramide-kinase activity. Overexpression of CERKL protects cells from apoptosis in oxidative stress conditions. . |
Accessions | ENST00000339098.9 [Q49MI3-1] G0XYD8 ENST00000410087.8 [Q49MI3-2] ENST00000452174.5 [Q49MI3-8] A0A804HIX5 ENST00000479558.5 G0XYE7 Q5DVJ3 ENST00000374969.6 [Q49MI3-4] ENST00000374970.6 [Q49MI3-3] ENST00000409440.7 [Q49MI3-9] ENST00000421817.5 [Q49MI3-8] ENST00000684145.1 ENST00000374967.6 [Q49MI3-7] Q49MI3 |